Michael Angelo Gaglia, Jr. , MD, MSc, FACC

Areas of Treatment:

Specialties:

  • Cardiology
  • Cardiovascular Disease

Title:

  • Assistant Professor of Clinical Medicine

Department:

Locations:

Background:

Selected First-Author Publications:

Systematic review of thienopyridine discontinuation and its impact upon clinical outcomes.European Heart Journal 2011; 32:2358-64.

Outcomes of patients with acute myocardial infarction from a saphenous vein graft culprit undergoing percutaneous coronary intervention. Catheterization and Cardiovascular Interventions 2011; 78:23-9.

Effect of insurance type on adverse cardiac events after percutaneous coronary intervention.American Journal of Cardiology 2011; 107:675-80.

Overview of the 2010 Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee meeting regarding ticagrelor.Circulation 2011; 123:451-6.

Correlation between light transmission aggregometry, VerifyNow P2Y12, and VASP-P platelet reactivity assays following percutaneous coronary intervention.Journal of Interventional Cardiology 2011; 24:529-34.Circulation 2011; 123:451-6.

Insurance type influences the use of drug-eluting stents. JACC: Cardiovascular Interventions 2010; 3:773-9.

Education:

  • Doctor of Medicine, University of Pittsburgh School of Medicine, 2001
  • Master of Science, University of Pittsburgh, 2007

Residencies:

  • University of Michigan Medical Center, Internal Medicine-Pediatrics, 2001 - 2005

Fellowships:

  • Washington Hospital Center/Georgetown University, Cardiovascular Disease, 2007-2009
  • Washington Hospital Center/Georgetown University, Interventional Cardiology, 2009-2011

Board Certification:

  • American Board of Internal Medicine - Cardiovascular Disease
  • American Board of Internal Medicine - Interventional Cardiology

Awards:

  • Young Leadership Recognition Program , Cardiovascular Research Technologies (CRT), 2012
  • High on-treatment platelet reactivity is associated with periprocedural myocardial infarction. Top ten abstracts, CRT 2011
  • Correlates and consequences of in-hospital gastrointestinal bleeding following percutaneous coronary intervention. Top 25 abstracts, Transcatheter Cardiovascular Therapeutics (TCT) 2010
  • Adverse outcomes in patients prescribed a proton pump inhibitor following percutaneous coronary intervention with drug-eluting stents. Top ten abstracts, CRT 2010

Languages:

  • English